{"@id":"https://bioecon.ru/technology/autologous-tumor-lysate-vaccine/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/autologous-tumor-lysate-vaccine/","json":"https://bioecon.ru/api/v1/technology/autologous-tumor-lysate-vaccine/index.json"},"id":"autologous-tumor-lysate-vaccine","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/botanical-solution-inc/","https://bioecon.ru/companies/medtronic/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/gsk/"]},"maturity":7,"name":"Вакцины на основе аутологичного лизата опухолевых клеток","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Сбор опухолевой ткани"},{"n":2,"title":"Радиационная и термическая инактивация"},{"n":3,"title":"Формулирование с адъювантом"},{"n":4,"title":"Внутрикожная иммунизация"}],"summary":"Персонализированные противоопухолевые вакцины из подвергнутой лизису и облучению аутологичной опухолевой ткани пациента в комбинации с интерфероном-гамма для предотвращения рецидива рака почки.","url":"/technology/autologous-tumor-lysate-vaccine/","verified":"2026-11-22"}